What are the side effects of immunotherapy for Multiple Myeloma
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Side Effects of Immunotherapy for Multiple Myeloma
Immunotherapy is an important treatment approach for multiple myeloma that works by enhancing your body's immune system to fight cancer cells. However, like all cancer treatments, immunotherapy can cause side effects. Let me break down what you should know.
Types of Immunotherapy Used in Myeloma
According to the NCCN Guidelines for Multiple Myeloma, the main immunotherapy drugs used are:
- Immunomodulators (like lenalidomide, pomalidomide, and thalidomide)
- Monoclonal antibodies (like daratumumab and isatuximab)
- CAR T-cell therapy (a newer, more advanced form of immunotherapy)
Each type has different side effects, so let me explain them by category.
Side Effects of Immunomodulators
Immunomodulators are oral drugs (pills) that are often taken for many months or even years. According to the NCCN Guidelines, common side effects include:
Common side effects:
- Drowsiness and fatigue (extreme tiredness)
- Constipation or diarrhea
- Skin rash
- Low blood cell counts (which can increase infection risk)
- Serious blood clots (a potentially dangerous complication)
- Peripheral neuropathy (numbness, tingling, or pain in hands and feet)
Important note: Thalidomide tends to cause more side effects than other immunomodulators. Additionally, immunomodulators can cause birth defects, so it's critical to avoid pregnancy while taking these medications.
Side Effects of Monoclonal Antibodies
Monoclonal antibodies like daratumumab work by attaching to cancer cells and marking them for destruction by your immune system. These are typically given by IV infusion or injection.
Common side effects may include:
- Fatigue and weakness
- Headaches
- Nausea and vomiting
- Diarrhea
- Low blood cell counts
- Rash
- Muscle aches
- Shortness of breath
- Numbness or tingling in hands or feet
Side Effects of CAR T-Cell Therapy
CAR T-cell therapy is a more advanced form of immunotherapy where your own T cells (a type of white blood cell) are removed, modified in a laboratory to better recognize cancer cells, and then returned to your body. According to the NCCN Guidelines, this approach can cause unique side effects:
Specific CAR T-cell side effects:
- Headaches and confusion
- Seizures (in some cases)
- Cytokine release syndrome (CRS) — a potentially serious condition where your immune system releases too many signaling molecules. Symptoms include:
- Fever and chills
- Nausea
- Headaches
- Racing heartbeat
- Low blood pressure
- Trouble breathing
Cytokine release syndrome requires close medical monitoring and can be managed with appropriate medical care.
General Side Effects Across Immunotherapy Types
Depending on which immunotherapy you receive, you might experience:
- Blood-related problems: Low white blood cells (increased infection risk), low red blood cells (anemia/fatigue), low platelets (bleeding/bruising)
- Neurological effects: Numbness, tingling, confusion, or headaches
- Gastrointestinal issues: Nausea, vomiting, diarrhea, constipation
- Systemic symptoms: Fatigue, weakness, fever, chills
- Skin reactions: Rash or other skin changes
Important Context: Managing Side Effects
The NCCN Guidelines emphasize that:
✅ Not all side effects occur in every patient — some people experience many side effects while others have few
✅ Most side effects appear early and go away after treatment ends, though some can be long-term
✅ Your care team can help manage side effects — there are medications and strategies to reduce symptoms and prevent complications
✅ Tell your treatment team immediately if you experience any side effects, especially serious ones like difficulty breathing, chest pain, severe headaches, or signs of infection
Questions to Ask Your Healthcare Team
Since your specific situation is unique, here are important questions to discuss with your oncologist:
-
Which immunotherapy drug(s) are you recommending for me, and what are the most common side effects I should expect?
-
How will you monitor me for serious side effects like blood clots or cytokine release syndrome?
-
What symptoms should I report immediately, and how do I reach you if problems occur?
-
Are there medications or strategies to prevent or manage specific side effects (like neuropathy or constipation)?
-
How long will I need to take this immunotherapy, and will side effects improve over time?
Key Takeaway
Immunotherapy for multiple myeloma can be highly effective, but it's important to understand potential side effects so you can recognize them early and work with your care team to manage them. According to the NCCN Guidelines for Multiple Myeloma, your oncologist will determine the most appropriate immunotherapy approach for YOUR specific case based on your overall health, other medical conditions, and how your myeloma responds to treatment.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Multiple Myeloma (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with treatment for Multiple Myeloma patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
What is the life expectancy for multiple myeloma cancer
I understand this is one of the most important questions you might have. Let me share what the current medical evidence shows, while being clear about
What is the 5-year survival rate for multiple myeloma
I appreciate this important question, but I need to be transparent with you: the NCCN Guidelines for Patients materials I have access to don't include
What is the average survival rate for multiple myeloma by stage
I appreciate this important question. However, I need to be direct with you: the NCCN Guidelines for Patients that I have access to do not include spe